Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma

Clinical trial NCT02689869 · UNKNOWN

Trial details

NCT number: NCT02689869
Sponsor: Ludwig-Maximilians - University of Munich
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent Non-Hodgkin Lymphoma

Start date: 2016-04-01
Primary completion: 2022-04-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.